Paper39738591
First clinical and pedigree study of rare HBB: c.316-90 A > G variant in β-globin gene in Chinese population using third-generation sequencing.
Zhuang J and 4 others. Ann Hematol, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. First clinical and pedigree study of rare HBB: c.316-90 A > G variant in β-globin gene in Chinese population using third-generation sequencing. Papers, record 39738591. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39738591
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- First clinical and pedigree study of rare HBB: c.316-90 A > G variant in β-globin gene in Chinese population using third-generation sequencing.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| beta-Globins | Major topic |
| beta-Thalassemia | Major topic |
| High-Throughput Nucleotide Sequencing | Major topic |
| Point Mutation | Major topic |
| Adult | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| China | |
| Pedigree | |
| East Asian People |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2021YX005 | Huaqiao University Joint of Hospital and University Innovation Project | PubMed | ||
| cqzdsys-2022-01 | Fujian Provincial Key Laboratory of Prenatal Diagnosis and Birth Defects open project | PubMed |
Source PubMed
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11283697 | Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias. | Nat Rev Genet | 2001 | https://conductscience.org/library/papers/11283697 | PubMed |
| 2 | 35691301 | Thalassaemia. | Lancet | 2022 | https://conductscience.org/library/papers/35691301 | PubMed |
| 3 | 23378598 | The prevention of thalassemia. | Cold Spring Harb Perspect Med | 2013 | https://conductscience.org/library/papers/23378598 | PubMed |
| 4 | 27847257 | New trend in the epidemiology of thalassaemia. | Best Pract Res Clin Obstet Gynaecol | 2017 | https://conductscience.org/library/papers/27847257 | PubMed |
| 5 | 39354459 | Application of third-generation sequencing technology for identifying rare α- and β-globin gene variants in a Southeast Chinese region. | BMC Med Genomics | 2024 | https://conductscience.org/library/papers/39354459 | PubMed |
| 6 | 35639603 | Third-Generation Sequencing as a New Comprehensive Technology for Identifying Rare α- and β-Globin Gene Variants in Thalassemia Alleles in the Chinese Population. | Arch Pathol Lab Med | 2023 | https://conductscience.org/library/papers/35639603 | PubMed |
| 7 | 38693200 | Molecular characterization of similar Hb Lepore Boston-Washington in four Chinese families using third generation sequencing. | Sci Rep | 2024 | https://conductscience.org/library/papers/38693200 | PubMed |
| 8 | 25737641 | Recent trends in the gene therapy of β-thalassemia. | J Blood Med | 2015 | https://conductscience.org/library/papers/25737641 | PubMed |
| 9 | 36246595 | Molecular prevalence of HBB-associated hemoglobinopathy among reproductive-age adults and the prenatal diagnosis in Jiangxi Province, southern central China. | Front Genet | 2022 | https://conductscience.org/library/papers/36246595 | PubMed |
| 10 | 36685902 | Identification of rare thalassemia variants using third-generation sequencing. | Front Genet | 2022 | https://conductscience.org/library/papers/36685902 | PubMed |
| 11 | 29109544 | Mapping and phasing of structural variation in patient genomes using nanopore sequencing. | Nat Commun | 2017 | https://conductscience.org/library/papers/29109544 | PubMed |
| 12 | 32473995 | Long-Molecule Sequencing: A New Approach for Identification of Clinically Significant DNA Variants in α-Thalassemia and β-Thalassemia Carriers. | J Mol Diagn | 2020 | https://conductscience.org/library/papers/32473995 | PubMed |
| 13 | 35181504 | Third-generation sequencing: A novel tool detects complex variants in the α-thalassemia gene. | Gene | 2022 | https://conductscience.org/library/papers/35181504 | PubMed |
| 14 | 35701592 | Analysis of rare thalassemia genetic variants based on third-generation sequencing. | Sci Rep | 2022 | https://conductscience.org/library/papers/35701592 | PubMed |
| 15 | 31839063 | [Analysis on the Genotype of 5018 Cases of Thalassemia in Hunan Area]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2019 | https://conductscience.org/library/papers/31839063 | PubMed |
| 16 | 3048433 | Molecular basis and prenatal diagnosis of beta-thalassemia. | Blood | 1988 | https://conductscience.org/library/papers/3048433 | PubMed |
| 17 | 28865746 | Rapid Targeted Next-Generation Sequencing Platform for Molecular Screening and Clinical Genotyping in Subjects with Hemoglobinopathies. | EBioMedicine | 2017 | https://conductscience.org/library/papers/28865746 | PubMed |
| 18 | 30837609 | Molecular characterization of thalassemia and hemoglobinopathy in Southeastern China. | Sci Rep | 2019 | https://conductscience.org/library/papers/30837609 | PubMed |
| 19 | 23926004 | [Molecular epidemiological analysis of α- and β-thalassemia in Fujian province]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2013 | https://conductscience.org/library/papers/23926004 | PubMed |
| 20 | 36519257 | Application of third-generation sequencing for genetic testing of thalassemia in Guizhou Province, Southwest China. | Hematology | 2022 | https://conductscience.org/library/papers/36519257 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41954743 | First clinical and molecular characterization of two rare complex β-globin variants in Chinese population using third generation sequencing. | Ann Hematol | 2026 | https://conductscience.org/library/papers/41954743 | PubMed |
| 41608324 | Current research status of third-generation sequencing technology in thalassemia detection. | Front Pediatr | 2025 | https://conductscience.org/library/papers/41608324 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| HBA1 | 3039 | PubTator's text mining | https://conductscience.org/library/genes/3039 | NCBI Gene |
| HBA2 | 3040 | PubTator's text mining | https://conductscience.org/library/genes/3040 | NCBI Gene |
| HBB | 3043 | PubTator's text mining | https://conductscience.org/library/genes/3043 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39738591
GET https://conductscience.org/api/papers/v1/39738591/references?page=2